Avalon GloboCare Corp (NASDAQ:ALBT) officially unveiled its KetoAir breathalyzer device in the United States at the Hack Your Health by KetoCon 2024 Conference.
Specifically engineered for ketogenic health management, KetoAir utilizes nano-sensor-based technology and AI algorithms to not only assess the user's ketosis status but also seamlessly record diet and exercise details into an app.
The breathalyzer boasts features such as Hot App shareable technology with AI-enabled software.
The “Blow to Know” technology delivers precise and immediate results achievable with a single exhale, enabling users to monitor how various foods and activities influence their ketone levels.
Having previously announced plans for commercialization, Avalon GloboCare has now taken the final steps towards initiating sales of the KetoAir breathalyzer. The company believes the device will address a gap in the market by offering a non-invasive daily test with improved precision and effectiveness.
Following its launch, consumers will have the exclusive opportunity to purchase the KetoAir breathalyzer at the newly designed website KetoAir.com.
“Our initial focus will revolve around targeting the diabetes reversal and obesity markets to help self-management using the KetoAir innovation for ketogenic health management,” Avalon CEO David Jin said in a statement.
“With the ketogenic diet proving effective in addressing both diabetes and weight management, we see a lot of potential in tackling these critical health concerns.
“We can't wait to introduce the KetoAir to individuals keen on elevating their health and wellness journey.”